Directors & Officers
| Name | Title | Year Born |
|---|---|---|
| Dr. Rene Faber | CEO & Director | 1975 |
| Ms. Petra Muller | Head of Investor Relations | NA |
DIM
Sartorius Stedim Biotech SA
ISIN
FR0013154002
Employees
10,483
Phone
33 4 42 84 56 00
Fiscal year end
December
Address
Zone Industrielle Les Paluds, Aubagne, France, 13781
223.40
-5.00 (-2.19%)
EUR · PA
52-week range
150.00
228.40
Trading at 94% of the 52-week range
Market Cap
22.22B
P/E Ratio
68.80
Forward P/E
38.76
Book Value
44.93
Div. Yield
0.00%
% Institutions
11.62%
% Insiders
71.50%
1 Year
+8.5%3 Year
+27.9%10 Year
+284.9%Description
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiology testing, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; screening instruments; biomolecule analysis tools; batch liquid chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; water purification systems; and weighing products. In addition, the company offers data analytics software; process automation platform and software; and transfection reagents and plasmid DNA solutions. The company has a collaboration with Bio Usawa Biotechnology, Ltd. focusing on developing and manufacturing monoclonal antibodies in Sub-Saharan Africa to tackle oncology, diabetes-induced eye diseases, infectious diseases, and autoimmune conditions. It serves manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Actions
Add an action for DIM.PA, or sign in to see your action list.
People
Financial Highlights
Market Cap:
$22.22B
EBITDA:
$835.50M
P/E Ratio:
$68.80
PEG Ratio:
$1.59
Book Value:
$44.93
Dividend/Share:
$0.00
Dividend Yield:
0.00%
Earnings/Share:
$3.32
Profit Margin:
10.58%
Operating Margin:
19.83%
ROA (TTM):
4.61%
ROE (TTM):
7.69%
Revenue (TTM):
$3.06B
Revenue/Share (TTM):
$31.48
Earnings Growth (YOY):
48.50%
Revenue Growth (YOY):
8.00%
Valuation Metrics
Enterprise Value:
$23.64B
Trailing P/E:
68.80
Forward P/E:
38.76
Shares Statistics
Shares Outstanding:
97.29M
Shares Float:
27.78M
% Insiders:
71.50%
% Institutions:
11.62%
Stock Price History
1 Year Price History
3 Years Price History
10 Years Price History
Max Price History
Financial Charts
Revenue, Net Income & Operating Cash Flow (Yearly)
Change % vs Prior Year
Revenue, Net Income & Operating Cash Flow (Quarterly)
Change % vs Prior Quarter
Operating Expenses (Yearly)
Operating Expenses (Quarterly)
Balance Sheet (Yearly)
Balance Sheet (Quarterly)
Assets Breakdown (Yearly)
Assets Breakdown (Quarterly)
Liabilities Breakdown (Yearly)
Liabilities Breakdown (Quarterly)
Income Statement Waterfall
Line Item
Step Type
Value
Revenue
adjust
$2.97B
Cost of Goods Sold
adjust
$-1.62B
Gross Profit
subtotal
$1.35B
SG&A
adjust
$-661.30M
R&D
adjust
$-132.60M
Other Operating Expense
adjust
$-2.40M
Operating Income
subtotal
$549.00M
Other / Non-Operating Items
adjust
$-283.40M
Net Income
subtotal
$265.60M
Earnings Per Share (EPS) History
Financial Ratios
📦 Raw API Data (JSON Explorer)
Comprehensive raw data returned from the EOD Fundamentals API. Expand sections below to drill down.